Filing Details

Accession Number:
0001209191-13-057541
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-17 19:07:00
Reporting Period:
2013-12-16
Filing Date:
2013-12-17
Accepted Time:
2013-12-17 19:07:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1172480 Santarus Inc SNTS Pharmaceutical Preparations (2834) 330734433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286098 Kent Snyder C/O Santarus, Inc.
3611 Valley Centre Drive #400
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-16 2,000 $1.18 2,000 No 4 M Direct
Common Stock Acquisiton 2013-12-16 5,500 $2.02 7,500 No 4 M Direct
Common Stock Disposition 2013-12-16 7,500 $31.95 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2013-12-16 2,000 $0.00 2,000 $1.18
Common Stock Stock Options (right to buy) Disposition 2013-12-16 5,500 $0.00 5,500 $2.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-16 No 4 M Direct
26,500 2018-06-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By Family Trust
Footnotes
  1. This exercise and this sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/14/2013.
  2. The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.94 to $31.955 per share. The reporting person undertakes to provide to Santarus, Inc., any security holder of Santarus, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  3. By the Snyder Family Trust dated July 17, 2000.
  4. Fully exercisable.
  5. Not applicable to this transaction.